181 related articles for article (PubMed ID: 16879970)
1. Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group.
Naganawa A; Matsui T; Ima M; Saito T; Murota M; Aratani Y; Kijima H; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2006 Nov; 14(21):7121-37. PubMed ID: 16879970
[TBL] [Abstract][Full Text] [Related]
2. Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists.
Naganawa A; Matsui T; Saito T; Ima M; Tatsumi T; Yamamoto S; Murota M; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Oct; 14(19):6628-39. PubMed ID: 16784865
[TBL] [Abstract][Full Text] [Related]
3. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
[TBL] [Abstract][Full Text] [Related]
5. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies.
Asada M; Iwahashi M; Obitsu T; Kinoshita A; Nakai Y; Onoda T; Nagase T; Tanaka M; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2010 Feb; 18(4):1641-58. PubMed ID: 20129791
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel glycine sulfonamide antagonists for the EP1 receptor.
McKeown SC; Hall A; Blunt R; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Healy MP; Johnson MR; Lorthioir O; Michel AD; Naylor A; Lewell X; Roman S; Watson SP; Winchester WJ; Wilson RJ
Bioorg Med Chem Lett; 2007 Mar; 17(6):1750-4. PubMed ID: 17236765
[TBL] [Abstract][Full Text] [Related]
7. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.
Asada M; Obitsu T; Kinoshita A; Nagase T; Yoshida T; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Nakai H; Toda M; Tobe Y
Bioorg Med Chem; 2010 May; 18(9):3212-23. PubMed ID: 20385498
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.
Asada M; Obitsu T; Kinoshita A; Nakai Y; Nagase T; Sugimoto I; Tanaka M; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem Lett; 2010 Apr; 20(8):2639-43. PubMed ID: 20346663
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological relationships of 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents.
Lai YY; Huang LJ; Lee KH; Xiao Z; Bastow KF; Yamori T; Kuo SC
Bioorg Med Chem; 2005 Jan; 13(1):265-75. PubMed ID: 15582470
[TBL] [Abstract][Full Text] [Related]
10. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J
Bioorg Med Chem Lett; 2007 Feb; 17(3):732-5. PubMed ID: 17098427
[TBL] [Abstract][Full Text] [Related]
11. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: discovery and exploration of the carboxyamide side chain.
Asada M; Obitsu T; Nagase T; Tanaka M; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2010 Jan; 18(1):80-90. PubMed ID: 20004584
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors.
Rönn R; Gossas T; Sabnis YA; Daoud H; Kerblom E; Danielson UH; Sandström A
Bioorg Med Chem; 2007 Jun; 15(12):4057-68. PubMed ID: 17449253
[TBL] [Abstract][Full Text] [Related]
14. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
Hall A; Billinton A; Bristow AK; Brown SH; Chowdhury A; Cutler L; Giblin GM; Goldsmith P; Hayhow TG; Kilford IR; Naylor A; Passingham B; Rawlings DA
Bioorg Med Chem Lett; 2008 Jul; 18(14):4027-32. PubMed ID: 18571922
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
[TBL] [Abstract][Full Text] [Related]
16. Potent and orally active ET(A) selective antagonists with 5,7-diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acid structures.
Yoshizumi T; Takahashi H; Ohtake N; Jona H; Sato Y; Kishino H; Sakamoto T; Ozaki S; Takahashi H; Shibata Y; Ishii Y; Saito M; Okada M; Hayama T; Nishikibe M
Bioorg Med Chem; 2004 May; 12(9):2139-50. PubMed ID: 15080914
[TBL] [Abstract][Full Text] [Related]
17. Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor.
Winters MP; Crysler C; Subasinghe N; Ryan D; Leong L; Zhao S; Donatelli R; Yurkow E; Mazzulla M; Boczon L; Manthey CL; Molloy C; Raymond H; Murray L; McAlonan L; Tomczuk B
Bioorg Med Chem Lett; 2008 Mar; 18(6):1926-30. PubMed ID: 18308567
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
Park CM; Kim SY; Park WK; Park NS; Seong CM
Bioorg Med Chem Lett; 2008 Jul; 18(14):3844-7. PubMed ID: 18602261
[TBL] [Abstract][Full Text] [Related]
19. Peri-substituted hexahydro-indolones as novel, potent and selective human EP3 receptor antagonists.
O'Connell M; Zeller W; Burgeson J; Mishra RK; Ramirez J; Kiselyov AS; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Feb; 19(3):778-82. PubMed ID: 19121942
[TBL] [Abstract][Full Text] [Related]
20. A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.
Yan L; Bertarelli DC; Hayallah AM; Meyer H; Klotz KN; Müller CE
J Med Chem; 2006 Jul; 49(14):4384-91. PubMed ID: 16821798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
